Company Filing History:
2 out of 869 
1 out of 318 
Years Active: 2016-2019
Title: Yoann Madec: Innovator in HIV Research
Introduction
Yoann Madec is a prominent inventor based in Paris, France. He has made significant contributions to the field of HIV research, focusing on identifying biomarkers that can predict disease progression. His work has the potential to improve the lives of many individuals living with HIV.
Latest Patents
Yoann Madec holds 2 patents related to his research. His latest patents include methods for identifying patients capable of controlling HIV progression. These inventions focus on the levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS. The inventions provide methods for identifying an antagonist form of IP-10 associated with HIV progression control, which can be used to enhance the immunological response of HIV patients.
Career Highlights
Throughout his career, Yoann Madec has worked with esteemed institutions such as Institut Pasteur and Assistance Publique-Hôpitaux de Paris. His research has been instrumental in advancing the understanding of HIV and its progression.
Collaborations
Yoann has collaborated with notable colleagues, including Michaela Müller-Trutwin and Mickaël J Y Ploquin. These collaborations have further enriched his research and contributed to the scientific community's knowledge of HIV.
Conclusion
Yoann Madec's innovative work in HIV research highlights the importance of identifying predictive biomarkers for disease progression. His contributions are paving the way for improved treatment options for patients living with HIV.